DK1021439T3 - Krystallinsk antifungal polymorf form - Google Patents

Krystallinsk antifungal polymorf form

Info

Publication number
DK1021439T3
DK1021439T3 DK98951994T DK98951994T DK1021439T3 DK 1021439 T3 DK1021439 T3 DK 1021439T3 DK 98951994 T DK98951994 T DK 98951994T DK 98951994 T DK98951994 T DK 98951994T DK 1021439 T3 DK1021439 T3 DK 1021439T3
Authority
DK
Denmark
Prior art keywords
polymorphic form
antifungal
crystalline
crystalline antifungal
polymorphic
Prior art date
Application number
DK98951994T
Other languages
Danish (da)
English (en)
Inventor
David R Andrews
William Leong
Anantha R Sudhakar
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK1021439T3 publication Critical patent/DK1021439T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK98951994T 1997-10-07 1998-10-05 Krystallinsk antifungal polymorf form DK1021439T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94618397A 1997-10-07 1997-10-07
PCT/US1998/020476 WO1999018097A1 (en) 1997-10-07 1998-10-05 Crystalline antifungal polymorph

Publications (1)

Publication Number Publication Date
DK1021439T3 true DK1021439T3 (da) 2004-05-10

Family

ID=25484068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98951994T DK1021439T3 (da) 1997-10-07 1998-10-05 Krystallinsk antifungal polymorf form

Country Status (30)

Country Link
EP (1) EP1021439B1 (enExample)
JP (4) JP2001519346A (enExample)
KR (1) KR100626109B1 (enExample)
CN (1) CN1125067C (enExample)
AR (1) AR015947A1 (enExample)
AT (1) ATE263163T1 (enExample)
AU (1) AU759982B2 (enExample)
BR (1) BR9812866A (enExample)
CA (1) CA2305803C (enExample)
CO (1) CO4970829A1 (enExample)
CZ (1) CZ299835B6 (enExample)
DE (1) DE69822859T2 (enExample)
DK (1) DK1021439T3 (enExample)
ES (1) ES2217594T3 (enExample)
HU (1) HU225233B1 (enExample)
ID (1) ID29290A (enExample)
IL (1) IL135331A (enExample)
IN (1) IN1998CH02232A (enExample)
MX (1) MX225999B (enExample)
MY (1) MY130126A (enExample)
NO (1) NO318827B1 (enExample)
NZ (1) NZ503662A (enExample)
PE (1) PE120499A1 (enExample)
PH (1) PH11998002606B1 (enExample)
PL (1) PL189317B1 (enExample)
PT (1) PT1021439E (enExample)
SK (1) SK285190B6 (enExample)
TW (1) TW589310B (enExample)
WO (1) WO1999018097A1 (enExample)
ZA (1) ZA989063B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (en) * 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
WO2011003992A1 (en) 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole
BR112012029227B1 (pt) * 2010-05-19 2020-01-07 Sandoz Ag Processo para a preparação de um composto quiral, composto quiral e uso de um composto
CN102892763B (zh) 2010-05-19 2016-03-09 桑多斯股份公司 泊沙康唑及泊沙康唑中间体的纯化
CN102892750B (zh) 2010-05-19 2016-03-02 桑多斯股份公司 制备手性酰肼的方法
BR112012029226A2 (pt) 2010-05-19 2015-10-20 Sandoz Ag processo para a preparação de um composto quiral, composto quiral cristalino, sal de hcl do composto quiral cristalino, composto quiral e uso do composto
WO2012172015A1 (en) 2011-06-16 2012-12-20 Sandoz Ag Process for the preparation of a chiral compound
EP2758385B1 (en) * 2011-09-19 2018-03-28 MSN Laboratories Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
US9670188B2 (en) 2013-07-25 2017-06-06 Sandoz Ag Process for the preparation of crystalline form IV of posaconazole
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
CN104387374A (zh) * 2014-10-21 2015-03-04 江苏恒盛药业有限公司 泊沙康唑晶型i的制备工艺
HRP20201343T1 (hr) 2014-10-21 2020-11-27 Ariad Pharmaceuticals, Inc. Kristalni oblici 5-kloro-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidin-2,4-diamina
EP3331501B1 (en) 2015-08-08 2019-09-11 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole
CA3009610C (en) 2015-12-24 2024-02-13 Takeda Pharmaceutical Company Limited Cocrystal of (s)-3-(1-((1-acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-1h-1,2,4-triazol-5(4h)-one, production method thereof and pharmaceutical composition containing said cocrystal
EP3210599B1 (en) 2016-02-26 2024-08-28 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
TR201722493A2 (tr) 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
WO2022034232A1 (en) 2020-08-13 2022-02-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant high-strength formulation containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
EP4181883B1 (en) 2021-11-25 2025-11-19 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
SK283035B6 (sk) * 1993-12-21 2003-02-04 Schering Corporation Tetrahydrofuránová zlúčenina, spôsob jej prípravy, jej farmaceuticky prijateľný ester, soľ a farmaceutický prostriedok
CN1078210C (zh) * 1994-01-24 2002-01-23 詹森药业有限公司 水溶性吡咯系杀真菌剂
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
PL319635A1 (en) * 1995-06-02 1997-08-18 Schering Corp Tetrahydrofurane-based antimycotic agents

Also Published As

Publication number Publication date
NO20001779D0 (no) 2000-04-06
PT1021439E (pt) 2004-07-30
NO318827B1 (no) 2005-05-09
MX225999B (es) 2005-02-02
IN1998CH02232A (enExample) 2005-03-04
HK1029588A1 (en) 2001-04-06
PH11998002606B1 (en) 2006-08-10
CN1281449A (zh) 2001-01-24
NZ503662A (en) 2002-10-25
EP1021439A1 (en) 2000-07-26
ID29290A (id) 2001-08-16
ES2217594T3 (es) 2004-11-01
HU225233B1 (en) 2006-08-28
CZ299835B6 (cs) 2008-12-10
CZ20001264A3 (cs) 2000-08-16
AR015947A1 (es) 2001-05-30
KR20010030959A (ko) 2001-04-16
AU9780398A (en) 1999-04-27
PL339659A1 (en) 2001-01-02
CN1125067C (zh) 2003-10-22
HUP0004899A3 (en) 2002-03-28
WO1999018097A1 (en) 1999-04-15
CA2305803C (en) 2009-12-22
PL189317B1 (pl) 2005-07-29
SK285190B6 (sk) 2006-08-03
SK5122000A3 (en) 2000-09-12
MXPA00003404A (es) 2000-11-01
CA2305803A1 (en) 1999-04-15
JP2008106075A (ja) 2008-05-08
ZA989063B (en) 1999-04-06
IL135331A0 (en) 2001-05-20
DE69822859D1 (de) 2004-05-06
DE69822859T2 (de) 2005-01-27
EP1021439B1 (en) 2004-03-31
PE120499A1 (es) 1999-12-04
JP2012153730A (ja) 2012-08-16
JP2001519346A (ja) 2001-10-23
NO20001779L (no) 2000-06-06
KR100626109B1 (ko) 2006-09-20
HUP0004899A2 (hu) 2002-02-28
ATE263163T1 (de) 2004-04-15
TW589310B (en) 2004-06-01
AU759982B2 (en) 2003-05-01
IL135331A (en) 2005-08-31
MY130126A (en) 2007-06-29
BR9812866A (pt) 2000-08-08
JP2012153729A (ja) 2012-08-16
CO4970829A1 (es) 2000-11-07

Similar Documents

Publication Publication Date Title
DK1021439T3 (da) Krystallinsk antifungal polymorf form
NO20003131D0 (no) Krystallinsk teriparatid
NO982599L (no) Antifungale sammensetninger med forbedret biotilgjenelighet
IS5479A (is) Efnasambönd
IS5478A (is) Efnasambönd
IS5477A (is) Efnasambönd
ID22850A (id) Senyawa-senyawa pirazina
EE200000321A (et) Uudsed ühendid
NO994877D0 (no) Kalsilytiske forbindelser
ID20323A (id) Senyawa-senyawa triazinilaminostilbena
EE9900448A (et) Ühendid
DE69714228D1 (de) Kristalline metallophosphate
PT867124E (pt) Composicao antifungica
EE9900475A (et) Ühendid
EE9900602A (et) Ühendid
ID22983A (id) Senyawa-senyawa fluorometoksimino
EE9900466A (et) Ühendid
DE69737634D1 (de) Insektizide oxadiazinverbindungen
SE9700751D0 (sv) Polymorphic compounds
SE9602477D0 (sv) Polymorphic compounds
SE9702775D0 (sv) Novel compounds
SE9704403D0 (sv) Novel compounds
SE9702200D0 (sv) Novel compounds
SE9701194D0 (sv) Novel compounds
SE9702199D0 (sv) Novel compounds